Pharma & Biotech Mergers & Acquisitions News
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Today's issue
Refine Search
Latest Mergers & Acquisitions News & Features
Generics
Aspire Pharma, a UK-based niche generics business, has announced the acquisition of all assets from Canute Pharma, further expanding its product range. 4 October 2024
Generics
Viatris has announced that the antitrust division of the US Department of Justice (DOJ) has concluded its investigation into Mylan and its former president, Rajiv Malik. 3 July 2024
Generics
An activist investor has renewed its effort to prevent Taro Pharmaceutical from accepting a buyout bid from Sun Pharmaceutical. 24 April 2024
Generics
Generic drugmaker Apotex has reached an agreement to acquire fellow Canada-based Searchlight Pharma. 5 April 2024
Generics
KELIX bio, an emerging markets biopharmaceuticals platform, has been sold to Mubadala Investment Company, an Abu Dhabi investor with over $276 billion in assets under management. 25 March 2024
Generics
Generic drugmaker Aspire Pharma today announced the successful completion of its acquisition of fellow UK-based Cenoté Pharma, in continuation of its strong organic growth. 11 March 2024
Generics
In a bid to focus on growth and innovation, Israeli generics drugmaker Teva Pharmaceutical is to hive off its active pharmaceutical ingredient (API) business. 1 February 2024
Generics
Sun Pharmaceutical Industries of India announced its intention to acquire all outstanding shares of US generics drugmaker Taro Pharmaceutical Industries at a price of $43 per share in cash, the companies announced. 19 January 2024
Generics
Taiwan’s Bora Pharmaceuticals is to acquire Upsher-Smith Laboratories, a US generics manufacturer. 17 January 2024
Generics
South Africa's largest drugmaker Aspen Pharmacare has announced an agreement with newly-independent generics drugmaker Sandoz, related to its Chinese business. 7 December 2023
Generics
Portuguese contract development and manufacturing organization (CDMO) Hovione has acquired the start-up ExtremoChem for an undisclosed amount. 20 November 2023
Generics
The Indian pharma and healthcare sector has witnessed a 298% jump in deals during the third quarter of 2023 compared to the same period last year. 8 November 2023
Generics
A confluence of factors is creating a conducive environment for mergers and acquisitions (M&As) to pick up pace in India. 23 October 2023
Generics
USA-based drugmaker Viatris has announced a series of divestitures as part of a strategy to narrow the company’s focus. 3 October 2023
Generics
Indian drugmaker Glenmark Pharmaceuticals has entered into a definitive agreement with Nirma Limited to divest a 75% stake in its subsidiary, Glenmark Life Sciences Limited (GLS), which focuses on producing active pharmaceutical ingredients (APIs). 22 September 2023
Generics
Shares of Hyderabad, India-headquartered Suven Pharmaceuticals hit a fresh 52-week high on the bourses after the Indian government gave the green signal to foreign direct investment (FDI) of up to $1.15 billion by drug major Cyprus-based Berhyanda. 19 September 2023
Generics
Several international investors and fund managers have expressed an interest in investing in the Indian pharmaceutical and biotechnology sectors, underlining the need to establish a platform to facilitate the transition of global capital flows into the domestic economy. 14 April 2023
Generics
In what could well be India's biggest pharma deal, China's Fosun Pharma-owned Gland Pharma is on the block. A number of private equity firms have been approached, including Baring Private Equity, Bain Capital, Blackstone, Carlyle, and KKR. 19 December 2022
Generics
Generics major Viatris yesterday said it intends to create an ophthalmology franchise by acquiring two companies, Oyster Point Pharma (Nasdaq: OYST) and Famy Life Sciences. 8 November 2022
Generics
Private equity firm SK Capital Partners has entered into a deal to acquire Apotex Pharmaceutical Holdings, a Canada-based generic drugmaker with products across all major therapeutic areas for patients around the world. 29 September 2022
Generics
Specialty generic drugmaker Akorn is crying foul at news which sent its share price sliding by 30% on Monday. 23 April 2018
Generics
Sanofi has entered into exclusive negotiations to sell Zentiva, its European generics business, to global private equity firm Advent International for 1.9 billion euros ($2.35 billion), the French pharma major announced today. 17 April 2018
Generics
Eisai and fellow Japanese firm Nichi-Iko Pharmaceutical have agreed terms for a strategic capital and business alliance in the generics sector. 28 March 2018
Generics
Switzerland’s Novartis is mulling a sale of its generic dermatologics business, which primarily does business in the USA, according to Reuters. 19 February 2018
Generics
An increased dependence on the import of active pharmaceutical ingredients (APIs) from China is raising national security concerns in India, with the Health Ministry contending it is technically destroying indigenous manufacturing, reports The Pharma Letter’s India correspondent. 9 February 2018
Generics
It has emerged that the number of industry players in the running to buy Sanofi’s European generics business Zentiva has been whittled down to two. 6 February 2018
Generics
Bangladesh's largest drugmaker Beximco Pharmaceuticals says it has now confirmed its previously-announced acquisition of Nuvista Pharma, a leading pharma company in Bangladesh specializing in hormones and steroid drugs. 19 January 2018
Generics
Indian drugmakers Aurobindo, Zydus Cadila, Torrent Pharmaceuticals and Intas Pharmaceuticals are among suitors vying for Sanofi’s (Euronext: SAN) attention, as the French drugmaker looks to offload its European generics business. 12 January 2018
Generics
In a bid to change direction, formerly Greece-based Pharmathen is now shedding its shedding its business in that country. 30 November 2017
Generics
Taipei-based generics maker TWi Pharmaceuticals has bought Synpac-Kingdom Pharmaceutical (SKP), another generics supplier known for ophthalmic treatments, for NT$1.8 billion ($59.8 million), reports The Pharma Letter’s China correspondent Wang Fangqing. 17 November 2017
Generics
Japanese drugmaker Sawai Pharmaceutical will sell a 20% stake in its US subsidiary (Sawai America) to Sumitomo Corporation of Americas (SCOA), a subsidiary of Sumitomo Corporation, one of Japan's leading general trading houses. 13 November 2017
Generics
US pharma giant Pfizer revealed on Friday that it has sold its 49% equity share in its joint venture, Hisun-Pfizer Pharmaceutical to Sapphire (HK) Holdings Limited. 13 November 2017
Generics
Indian generic drugmaker Alembic Pharmaceuticals has completed a buy of a New-Jersey based company that takes its number of abbreviated new drug application (ANDA) approvals in the USA to 69. 1 November 2017
Generics
Shares in Impax Laboratories were worth 10% less at $18 after Tuesday morning’s trading. 17 October 2017
Generics
Following a public comment period, the Federal Trade Commission (FTC) has approved a final order designed to remedy the anticompetitive effects resulting from Baxter International’s proposed $625 million acquisition of India-based Claris Lifesciences’ injectable drugs business. 31 August 2017
Generics
Shares of German generics drugmaker Stada Arzneimittel leapt 13.18% to 72.55 euros on Friday, after it became clear that the proposed 4.1 billion-euro ($4.8 billion) takeover of the company would finally proceed. 21 August 2017
Generics
Perrigo soared 17% to $77.90 by late morning on Thursday, having surged as much as 20.4%, after the company revealed it has reached an agreement to divest its Israel Active Pharmaceutical Ingredient business. 11 August 2017
Generics
A two-tier manufacturing market and forecast increased acquisitions by Indian companies, along with a notable improvement in the international reputation of Indian made pharmaceuticals have been identified in a new report for CPhI titled: 2017 India Pharma Market Report. 10 August 2017
Generics
The Cabinet Committee on Economic Affairs of India (CCEA) has decided to block Shanghai Fosun Pharmaceutical’s 8.5 billion yuan ($1.3 billion) takeover of the Indian drugmaker Gland Pharma, according to reports. 3 August 2017
Generics
The executive and the supervisory boards of German generic drugs maker Stada Arzneimittel (SAZ: Xetra) today published their reasoned joint statement on the renewed voluntary public takeover offer by Nidda Healthcare Holding, the acquiring company of Bain Capital and Cinven, for all outstanding shares in Stada. 25 July 2017
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze